What has changed in the pharmaceutical care after COVID-19: Pharmacists’ perspective

Main Article Content

Keywords

Pharmaceutical care, COVID-19, Telepharmacy, Information technology tools, Medication dispensing, Medication review, Patient education

Abstract

Objectives: The study aimed to investigate the impact of Coronavirus disease (COVID-19) on the roles of hospital and community pharmacists in the United Arab Emirates (UAE) and to assess how COVID-19 has affected their roles concerning medication dispensing and review, patient education, and telepharmacy services. Methods: This was a face-to-face questionnaire-based study. A convenient sampling technique was used to collect responses from 428 licensed community and hospital pharmacists across the UAE. The study tool is a structured questionnaire. Data were cleaned and analysed through SPSS Version 26. Results: In terms of medication dispensing practice, 314 (73.4%) and 210 (49.1%) of pharmacists reported an increase in the dispensing of over the counter (OTC) medicines and antibiotics after COVID-19, respectively. Of the pharmacists included in the study, 380 (88.8%) and 328 (76.6%) reported an elevation in the engagement in patient education and medication review after COVID-19, respectively. On the other hand, 247 (57.7%) and 179 (41.8%) of pharmacists reported that the frequency of their pharmaceutical interventions and physicians’ acceptance of those interventions increased after COVID-19, which was significantly associated (p=0.01) with pharmacists’ ability to intervene on the dosage regimen of COVID-19 patient. Conclusion: Pharmaceutical care in the UAE has evolved after COVID-19, particularly in the aspects of medications dispensing, telepharmacy, and patientcentered services..

Abstract 1979 | PDF Downloads 334

References

1. Novel coronavirus (2019-nCoV). 2021.
2. COVID Live Update: Cases and Deaths from the Coronavirus - Worldometer. 2021.
3. Team EE. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Eurosurveillance. 2020;25(5):200131e. https://doi.org/10.2807/1560-7917.ES.2020.25.5.200131e
4. Wang C, Tee M, Roy AE, et al. The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia. PLoS One. 2021;16(2):e0246824. https://doi.org/10.1371/journal.pone.0246824
5. Mofijur M, Fattah MR, Alam MA, et al. Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemic. Sustain Prod Consum. 2021;26:343-359. https://doi.org/10.1016/j.spc.2020.10.016
6. Ghibu S, Juncan AM, Rus LL, et al. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021;18(18):9776. https://doi.org/10.3390/ijerph18189776
7. Lee DH, Watson KE, Al Hamarneh YN. Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: The INSPIRE Survey. Can Pharm J. 2021;154(6):368-373. https://doi.org/10.1177/17151635211028253
8. Ayati N, Saiyarsarai P, Nikfar S. Short and long term impacts of COVID-19 on the pharmaceutical sector. J Pharm Sci. 2020;28(2):799-805. https://doi.org/10.1007/s40199-020-00358-5
9. Nadeem MF, Samanta S, Mustafa F. Is the paradigm of community pharmacy practice expected to shift due to COVID-19? Research in social & administrative pharmacy: RSAP. 2021;17(1):2046-2048. https://doi.org/10.1016/j.sapharm.2020.05.021
10. DOH. DOH Standard on Tele-Medicine. 2020.
11. 800 Pharmacy.
12. Department of Health AD. Remote Healthcare Platform. https://doh.gov.ae/covid-19/Remote-Healthcare-Platform. 2020. https://doi.org/10.1089/tmj.2020.0283
13. Allemann SS, Van Mil JWP, Botermann L, et al. Pharmaceutical care: The PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544-55. https://doi.org/10.1007/s11096-014-9933-x
14. Visacri MB, Figueiredo IV, Lima T. Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Soc Adm Pharm. 2021;17(1):1799-1806. https://doi.org/10.1016/j.sapharm.2020.07.003
15. Ibrahim OM, Ibrahim RM, Ibrahim YA, et al. Shedding the light on Pharmacists’ roles during COVID-19 global pandemic. Saudi Pharm J. 2022;30(1):14-27. https://doi.org/10.1016/j.jsps.2021.12.003
16. Jordan D, Guiu-Segura JM, Sousa-Pinto G, et al. How COVID-19 has impacted the role of pharmacists around the world. Farm Hosp. 2021;45(2):89-95. https://doi.org/10.7399/fh.11652
17. Sample Size Calculator by Raosoft, Inc.
18. Cipolle RJ, Strand LM, Morley PC. Drug Therapy Problems. in Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services. 2012.
19. Al-Azzam SI, Alzoubi KH, AbuRuz S, et al. Drug-related problems in a sample of outpatients with chronic diseases: a crosssectional study from Jordan. Ther Clin Risk Manag. 2016;12:233-9. https://doi.org/10.2147/TCRM.S98165
20. Al-Quteimat OM, Amer AM. SARS-CoV-2 outbreak: How can pharmacists help? Res Soc Adm Pharm. 2021;17(2):480-482. https://doi.org/10.1016/j.sapharm.2020.03.018
21. Yimenu DK, Demeke CA, Kasahun AE. Impact of COVID-19 on Pharmaceutical Care Services and the Role of Community Pharmacists: A Multi-Center Cross-Sectional Study in Ethiopia. SAGE Open Nurs. 2021;7:23779608211025804. https://doi.org/10.1177/23779608211025804
22. Department of Health AD. Remote Healthcare Platform. https://doh.gov.ae/covid-19/Remote-Healthcare-Platform. 2020.
23. Department of Health AD. Latest information on Coronavirus COVID-19. https://www.doh.gov.ae/covid-19. 2020.
24. Campitelli MA Bronskill SE, Maclagan LC, et al. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021;4(8):e2118441. https://doi.org/10.1001/jamanetworkopen.2021.18441
25. Hashmi FK, Atif N, Malik UR, et al. Misinformation in Wake of the COVID-19 Outbreak: Fueling Shortage and Misuse of Lifesaving Drugs in Pakistan. Disaster Med Public Health Prep. 2021;15(4):e32-e33. https://doi.org/10.1017/dmp.2020.400
26. Knight BD, Shurgold J, Smith G, et al. The impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clin Microbiol Infect. 2022;28(3):426-432. https://doi.org/10.1016/j.cmi.2021.10.013
27. Gillies MB, Burgner DP, Ivancic L, et al. Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for postpandemic antibiotic stewardship. Br J Clin Pharmacol. 2022;88(3):1143-1151. https://doi.org/10.1111/bcp.15000
28. Aruru M, Truong HA, Clark S. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Soc Adm Pharm. 2021;17(1):1967-1977. https://doi.org/10.1016/j.sapharm.2020.04.002
29. Cadogan CA, Hughes CM. On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Soc Adm Pharm. 2021;17(1):2032-2035. https://doi.org/10.1016/j.sapharm.2020.03.015
30. Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social Adm Pharm. 2021;17(1):1964-1966. https://doi.org/10.1016/j.sapharm.2020.04.013
31. Linzer M, Stillman M, Brown R, et al. Preliminary Report: US Physician Stress During the Early Days of the COVID-19 Pandemic. Mayo Clin Proceedings Innov Qual Outcomes. 2021;5(1):127-136. https://doi.org/10.1016/j.mayocpiqo.2021.01.005
32. El Bizri L, Jarrar LG, Ali WKA, et al. The role of community pharmacists in increasing access and use of self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region: examples from Egypt, Jordan, Lebanon and Somalia. Heal Res Policy Syst. 2021;19(Suppl 1):49. https://doi.org/10.1186/s12961-021-00695-0

Most read articles by the same author(s)